Raymond James Financial’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.73M Buy
454,746
+179,834
+65% +$3.74M ﹤0.01% 2046
2025
Q4
$5.88M Buy
274,912
+27,490
+11% +$563K ﹤0.01% 2384
2025
Q3
$4.14M Sell
247,422
-180
-0.1% -$2.7K ﹤0.01% 2597
2025
Q2
$3.55M Buy
247,602
+11,279
+5% +$155K ﹤0.01% 2618
2025
Q1
$3.42M Buy
236,323
+2,666
+1% +$37.9K ﹤0.01% 2596
2024
Q4
$3.07M Buy
+233,657
New +$3.23M ﹤0.01% 2652

Other funds holding MD

Raymond James Financial's MD Position: Q1 2026 in Review

Raymond James Financial increased its Pediatrix Medical (MD) stake by 65% in Q1 2026, buying an estimated $3.74M and bringing the position to 454,746 shares worth $9.73M. The position accounts for ﹤0.01% of the portfolio, ranked #2046.

Raymond James Financial first reported a position in MD in Q4 2024 and has held it in 6 quarters since. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Raymond James Financial held 454,746 shares of Pediatrix Medical worth $9.73M as of Q1 2026.
  • Raymond James Financial bought 179,834 Pediatrix Medical shares in Q1 2026, an estimated $3.74M.
  • Pediatrix Medical made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #2046 holding.
  • Raymond James Financial first reported a position in Pediatrix Medical in Q4 2024 and has held it in 6 quarters since.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.